Optimizing Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation: Insights from the ORCA Trial—A Retrospective Study on 10 Years of Practice
(1) Background: Citrate is preferred in continuous renal replacement therapy (CRRT) for critically ill patients because it prolongs filter life and reduces bleeding risks compared to unfractionated heparin (UFH). However, regional citrate anticoagulation (RCA) can lead to acid–base disturbances, cit...
मुख्य लेखकों: | Rita Jacobs, Walter Verbrugghe, Jason Bouziotis, Ingrid Baar, Karolien Dams, Annick De Weerdt, Philippe G. Jorens |
---|---|
स्वरूप: | लेख |
भाषा: | English |
प्रकाशित: |
MDPI AG
2024-10-01
|
श्रृंखला: | Life |
विषय: | |
ऑनलाइन पहुंच: | https://www.mdpi.com/2075-1729/14/10/1304 |
समान संसाधन
-
Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy: Is Metabolic Fear the Enemy of Logic? A Systematic Review and Meta-Analysis of Randomised Controlled Trials
द्वारा: Rita Jacobs, और अन्य
प्रकाशित: (2023-05-01) -
Adverse events with regional citrate anticoagulation versus heparin anticoagulation during continuous renal replacement therapy: a systematic review and trial sequential analysis
द्वारा: Min-min Wang, और अन्य
प्रकाशित: (2023-10-01) -
Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy
द्वारा: Desheng Zhu, और अन्य
प्रकाशित: (2024-06-01) -
Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk
द्वारा: Jing Jiao, और अन्य
प्रकाशित: (2023-12-01) -
Anticoagulation strategies for pediatric continuous renal replacement therapy
द्वारा: Aakash Chandran Chidambaram, और अन्य
प्रकाशित: (2024-09-01)